52 research outputs found

    Measurement of key resonance states for the 40P(p,g)31S reaction rate, and the production of intermediate-mass elements in nova explosions

    Get PDF
    We report the first experimental constraints on spectroscopic factors and strengths of key resonances in the 30P(p, γ)31Sreaction critical for determining the production of intermediate-mass elements up to Ca in nova ejecta. The 30P(d, n)31Sreaction was studied in inverse kinematics using the GRETINA γ-ray array to measure the angle-integrated cross-sections of states above the proton threshold. In general, negative-parity states are found to be most strongly produced but the absolute values of spectroscopic factors are typically an order of magnitude lower than predicted by the shell-model calculations employing WBP Hamiltonian for the negative-parity states. The results clearly indicate the dominance of a single 3/2−resonance state at 196 keV in the region of nova burning T≈0.10–0.17GK, well within the region of interest for nova nucleosynthesis. Hydrodynamic simulations of nova explosions have been performed to demonstrate the effect on the composition of nova ejecta.Postprint (published version

    Single-particle shell strengths near the doubly magic nucleus 56Ni and the 56Ni(p,γ)57Cu reaction rate in explosive astrophysical burning

    Get PDF
    Angle-integrated cross-section measurements of the 56Ni(d,n) and (d,p) stripping reactions have been performed to determine the single-particle strengths of low-lying excited states in the mirror nuclei pair 57Cu−57Ni situated adjacent to the doubly magic nucleus 56Ni. The reactions were studied in inverse kinematics utilizing a beam of radioactive 56Ni ions in conjunction with the GRETINA γ-array. Spectroscopic factors are compared with new shell-model calculations using a full pf model space with the GPFX1A Hamiltonian for the isospin-conserving strong interaction plus Coulomb and charge-dependent Hamiltonians. These results were used to set new constraints on the 56Ni(p,γ)57Cu reaction rate for explosive burning conditions in x-ray bursts, where 56Ni represents a key waiting point in the astrophysical rp-process.peerReviewe

    Ernst Laqueur (1880-1947): The Career of an Outsider

    No full text

    Methods for detection and confirmation of Hematide?/peginesatide in anti-doping samples.

    No full text
    Since the 1990's, cheating athletes have abused substances to increase their oxygen transport capabilities; among these substances, recombinant EPO is the most well known. Currently, other investigational pharmaceutical products are able to produce an effect similar to EPO but without having chemical structures related to EPO; these are the synthetic erythropoiesis stimulating agents (ESAs). Peginesatide (also known as Hematide?) is being developed by Affymax and Takeda and, if approved by regulatory authorities, could soon be released on the international market. To detect potential athletic abuse of this product and deter athletes who consider cheating, we initiated a collaboration to implement a detection test for anti-doping purposes. Peginesatide is a synthetic, PEGylated, investigational, peptide-based erythropoiesis-stimulating agent that is designed and engineered to stimulate specifically the erythropoietin receptor dimer that governs erythropoiesis. It is undetectable using current anti-doping tests due to its lack of sequence homology to EPO. To detect and deter potential abuse of peginesatide, we initiated an industry/antidoping laboratory collaboration to develop and validate screening and confirmation assays so that they would be available before peginesatide reaches the market. We describe a screening ELISA and a confirmation assay consisting of immune-purification followed by separation with SDS-PAGE and revelation with Western double blotting. Both assays can detect 0.5 ng/mL concentrations of peginesatide in blood samples, enabling detection for several days after administration of a physiologically relevant dose. This initial report describes experimental characterization of these assays, including testing with a blinded set of samples from a clinical study conducted in healthy volunteers
    corecore